The MousePhenomics division develops analytical tools and high-content assays to measure behaviour in animal models of brain disease. Automated, high-resolution multiparametric screening enables testing compounds on, for instance, memory improvement, attention deficits and anxiety.
In parallel, the company’s cellomics division develops high-content cellomics assays and performs contract research for in vitro drug screening on neuronal cells.
Thirdly, the company applies a suit of proprietary multivariate analyses (ACOHDA®) to integrate and compare molecular, cellular and behavioural data linked to the company’s databases.
Finally, the Sylics-management division hosts an alliance office that assembles and manages research consortia, assists in formulating applications, provides reporting services and mediates between private and academic partners.